BioPharma-Reporter

Pfizer has received a slap on the wrist from the @PMCPAUK but how much damage has this done and will it trigger internal changes at the pharma giant? Read our analysis biopharma-reporter.com/Article/2024/0…

Whether they recognise it or not, the entire pharma industry is involved in the business of health equity and championing it is critically important, @RKPimprint CCO of @Novartis told @RE_Pharma in her brilliant talk. biopharma-reporter.com/Article/2024/0…

Maya Martinez-Davis, president, US commercial at @GSK , outlined her approach to senior leadership @RE_Pharma biopharma-reporter.com/Article/2024/0…

Professor Luigi, of the San Raffaele Telethon Institute for Gene Therapy in Milan, tells us about his fascinating career in gene therapy... biopharma-reporter.com/Article/2024/0…

Big news for the pharma industry. A net positive or negative? biopharma-reporter.com/Article/2024/0…

Watch: Bio Pharma Reporter hosted a fascinating conversation at @Phacilitate's Advanced Therapies Week - with speakers from @organabio, @TrakCel_, @CatalentPharma. biopharma-reporter.com/Article/2024/0…

Weight loss drugs dominated the conversation at @Jefferies London Healthcare Conference. Read our recap of a panel discussing how CDMO's are approaching the market and getting ahead of the curve... biopharma-reporter.com/Article/2023/1…

Our first podcast of 2023 with Dr Sarah Bateup, therapy lead at @clerkenwell_uk... biopharma-reporter.com/Article/2023/1…

🚨 BREAKING NEWS: @SharpPackaging has acquired @BerkshireSM to offer a fully integrated small-to-medium scale sterile injectable service offering for the biopharma industry. biopharma-reporter.com/Article/2023/1…

While global biopharma firm @TakedaPharma used to be 'entirely reliant' on its CRO partners, the company is now striving to take control of its technology. Penny Carlson outlined the strategy at @veevasystems' R&D and Quality summit... biopharma-reporter.com/Article/2023/0… #takeda #veeva

A pleasure to speak with Lucy Jung, CEO of @CharcoLtd, about the company's innovative wearable device, her career background and fascination for problem-solving... biopharma-reporter.com/Article/2023/0…

Fantastic to speak with @AnebuloPharma's Simon Allen at Bio Boston about the rise of acute cannabinoid intoxication and the company's promising new drug to treat it... outsourcing-pharma.com/Article/2023/0…

From the #BIO2023 floor: we spoke to @Cytiva CEO Emmanuel Ligner about how the company's recent integration with @PallBiotech is a "winning recipe" and how Cytiva is staying plugged into the industry... biopharma-reporter.com/Article/2023/0…

@avacta has acquired @corisbio, a European manufacturer of rapid diagnostic test kits... biopharma-reporter.com/Article/2023/0…

Earnings miss, lowered outlook for @CatalentPharma biopharma-reporter.com/Article/2022/1…

.@AstraZeneca and @SanofiScience secure EU approval for antibody to prevent RSV in infants biopharma-reporter.com/Article/2022/1…

It's today! Join us for our free webinar on bioprocessing 4.0. Find out about what today's smart factory looks like; the role bioprocessing 4.0 has to play in the current energy crisis - and much more. Register here to listen live or on-demand. onlinexperiences.com/scripts/Server…

Join us tomorrow for our free-to-attend webinar, Bioprocessing 4.0! Register here: onlinexperiences.com/scripts/Server…

Join us next week for our free-to-attend webinar on Bioprocessing 4.0! Register here: onlinexperiences.com/Launch/QReg/Sh…

Synthego breaks ground on sgRNA manufacturing facility. The company plans to use the additional capacity to manufacture synthetic sgRNAs, used in the development of CRISPR-mediated cell and #gene therapies. @Synthego #GeneTherapy #celltherapy #CRISPR biopharma-reporter.com/Article/2022/0…